Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 133 shares at $246.21 ($33K) on 2022-05-16, disclosed to the SEC on 2022-05-18.
Scheduled sale ($33k) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $246.21 | 11 | $3K | 8.1% |
| 2 | $247.95 | 10 | $2K | 7.4% |
| 3 | $249.35 | 20 | $5K | 14.9% |
| 4 | $250.78 | 32 | $8K | 24.0% |
| 5 | $251.43 | 10 | $3K | 7.5% |
| 6 | $252.66 | 10 |
| $3K |
| 7.6% |
| 7 | $254.19 | 40 | $10K | 30.4% |
| Total | $251.19 avg | 133 | $33K | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |